Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic-pituitary-ovarian axis.
Chen X, Xiao Z, Cai Y, Huang L, Chen C.
Trends Endocrinol Metab. 2022 Mar;33(3):206-217. doi: 10.1016/j.tem.2021.12.004. Epub 2022 Jan 18.
ENDOCRINE OBESITY: Pituitary dysfunction in obesity.
Ruiz S, Vázquez F, Pellitero S, Puig-Domingo M.
Eur J Endocrinol. 2022 Apr 21;186(6):R79-R92. doi: 10.1530/EJE-21-0899.
Obesity disrupts the pituitary-hepatic UPR communication leading to NAFLD progression.
Qian Q, Li M, Zhang Z, Davis SW, Rahmouni K, Norris AW, Cao H, Ding WX, Hotamisligil GS, Yang L.
Cell Metab. 2024 Jul 2;36(7):1550-1565.e9. doi: 10.1016/j.cmet.2024.04.014. Epub 2024 May 7.
Severe Obesity Associated With Pituitary Corticotroph Hyperplasia and Neoplasia.
Lochner RH, Delfin L, Nezami BG, Cohen ML, Asa SL, Burguera B, Couce ME.
Endocr Pract. 2023 Jun;29(6):471-477. doi: 10.1016/j.eprac.2023.03.274. Epub 2023 Mar 31.
Obesity, Overweight, and Pituitary Stalk Interruption Syndrome in Children and Young Adults.
Nannette G, Bar C, Diene G, Pienkowski C, Oliver-Petit I, Jouret B, Cartault A, Porquet-Bordes V, Salles JP, Grunenwald S, Edouard T, Molinas C, Tauber M.
J Clin Endocrinol Metab. 2023 Jan 17;108(2):323-330. doi: 10.1210/clinem/dgac583.
Obesity and pituitary gland volume - a correlation study using three-dimensional magnetic resonance imaging.
Fehrenbach U, Jadan A, Auer TA, Kreutz K, Geisel D, Ziagaki A, Bobbert T, Wiener E.
Neuroradiol J. 2020 Oct;33(5):400-409. doi: 10.1177/1971400920937843. Epub 2020 Jul 15.
Silent pituitary adenoma and metabolic disorders: obesity, abnormal glucose tolerance, hypertension and dyslipidemia.
Baba N, Kameda H, Nakamura A, Yong Cho K, Nomoto H, Mitsuhashi T, Miyoshi H, Atsumi T.
Endocr J. 2021 Feb 28;68(2):195-200. doi: 10.1507/endocrj.EJ20-0185. Epub 2020 Oct 6.
The Safety and Efficacy of Growth Hormone Secretagogues.
Sigalos JT, Pastuszak AW.
Sex Med Rev. 2018 Jan;6(1):45-53. doi: 10.1016/j.sxmr.2017.02.004. Epub 2017 Apr 8.
Activity of the hypothalamic-pituitary-adrenal axis in different obesity phenotypes.
Pasquali R, Vicennati V.
Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S47-9.
Obesity dysregulates a pituitary-liver axis through disruption of the unfolded protein response.
Starling S.
Nat Rev Endocrinol. 2024 Jul;20(7):385. doi: 10.1038/s41574-024-01002-x.
